calltech-consultant.com

Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

4.7 (378) · € 6.00 · En stock

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Life, Free Full-Text

Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine? - Nitin Sharma, Giriraj T. Kulkarni, Anant Narayan Bhatt, Saurabh Satija, Lubhan Singh, Anjana Sharma, Kamal Dua, Ritu Karwasra

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand

Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2, Cell & Bioscience

PDF) In vitro efficacy of Artemisia extracts against SARS-CoV-2

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Medicinal Plants as COVID-19 Remedy

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective